NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/29/24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 04/29/24 | DEF 14A | Definitive proxy statements |
|
43 | |
| 03/29/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
198 |
| 03/27/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/25/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/25/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/25/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/21/24 | 8-K | Current report filing |
|
|
7 |
| 02/23/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/02/24 | 8-K | Current report filing |
|
|
4 |